Table 4.
Use of one adjuvant only | No adjuvant used | Crude OR | Adjusted OR | p | |
---|---|---|---|---|---|
Antibiotics | 31.8% (87/274) | 33.5% (4385/13098) | 0.92 (0.71–1.20) | 1.11 (0.75–1.64) | 0.59 |
Aspirin | 31.3% (135/431) | 33.5% (4337/12941) | 0.90 (0.73–1.08) | 1.48 (1.08–2.02) | 0.014 |
Enoxaparin/heparin | 28.7% (239/834) | 33.8% (4233/12538) | 0.79 (0.67–0.92) | 1.05 (0.76–1.45) | 0.76 |
Steroids | 29.0% (289/997) | 33.8% (4183/12375) | 1.05 (0.91–1.21) | 1.40 (1.11–1.77) | 0.004 |
Melatonin | 23.8% (81/341) | 33.7% (4391/13031) | 0.61 (0.47–0.79) | 0.66 (0.45–0.96) | 0.032 |
Dopamine Ag | 53.4% (31/58) | 33.4% (4441/13314) | 2.29 (1.33–3.96) | 1.58 (0.74–3.39) | 0.24 |
HCG infusion | 25.9% (49/189) | 33.6% (4423/13183) | 0.69 (0.49–0.97) | 0.74 (0.43–1.25) | 0.26 |
DHEA | 22.7% (17/75) | 33.5% (4455/13297) | 0.58 (0.33–1.03) | 1.09 (0.51–2.35) | 0.82 |
Testosterone | 11.0% (9/82) | 33.6% (4463/13290) | 0.24 (0.11–0.50) | 0.54 (0.20–1.46) | 0.23 |
Growth hormone | 19.2% (23/120) | 33.6% (4449/13252) | 0.47 (0.29–0.75) | 0.81 (0.41–1.61) | 0.55 |
Intralipid infusion | 28.9% (90/311) | 33.6% (4382/13061) | 0.81 (0.62–1.04) | 0.98 (0.61–1.59) | 0.98 |
Filgrastim | 20.6% (21/102) | 33.5% (4451/13270) | 0.51 (0.31–0.85) | 1.00 (0.41–2.41) | 1.00 |
Co-enzyme Q10 | 8.0% (2/25) | 33.5% (4470/13347) | 0.17 (0.03–0.75) | 1.22 (0.22–6.65) | 0.82 |